Trade Summary

3 days ago, Kapusta Matthew C, serving as CEO, MD at Uniqure N.V. (QURE), sold 34,437 shares at $9.95 per share, for a total transaction value of $342,648.00. Following this transaction, Kapusta Matthew C now holds 604,639 shares of QURE.

This sale represents a 5.00% decrease in Kapusta Matthew C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Uniqure N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.